CLICK ON YOUR PROVINCE TO ACCESS FULL COVERAGE DETAILS
Pr ILUMYA® (tildrakizumab injection) is indicated for the treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.9
Please consult the product monograph at:
http://info.ilumya.ca/Product_Monograph
for important information relating to contraindications, warnings, precautions, adverse reactions,
interactions, dosing and conditions of clinical use.
The Product Monograph is also available by calling our medical information department at:
1-844-924-0656.